Cipla LTD · 66-41 · INDIA
For Cipla LTD · 66-41 · INDIA, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is INDIA; product is Tadacip 20 | Tadacip 20; product code is 66 S - - 51 Tadalafil | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 03/14/2017; address is Khasra No. 509/1-2 & 520 , Vii-Bhagwanpur , Bhagwanpur, Uttaranchal INDIA, verified against its source on 2026-09-16.
- Firm
- Cipla LTD verified
- Import alert
- 66-41
- Import alert name
- Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- Country
- INDIA verified
- Address
- Khasra No. 509/1-2 & 520 , Vii-Bhagwanpur , Bhagwanpur, Uttaranchal INDIA verified
- Date published
- 03/14/2017 verified
- Product code
- 66 S - - 51 Tadalafil | 66 V - - 99 Miscellaneous Patent Medicines, Etc. each item verified
- Product
- Tadacip 20 | Tadacip 20 each item verified
What the source says
Cipla LTD Date Published : 03/14/2017 Khasra No. 509/1-2 & 520 , Vii-Bhagwanpur , Bhagwanpur, Uttaranchal INDIA 66 S - - 51 Tadalafil Date Published: 03/14/2017 Desc: Tadacip 20 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 03/14/2017 Desc: Tadacip 20
— accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_190.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.